NCT01980290View on ClinicalTrials.gov

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Hepatitis, Chronic

Trial Locations (18)

Unknown

Antwerp

Brussels

Genk

Haine-Saint-Paul

Lomme

Montpellier

Perpignan

Berlin

Biberach

Kassel

München

Münster

Maastricht

Lausanne

Zurich

Dundee

London

Nottingham

All Listed Sponsors

lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

NCT01980290 - Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C | Biotech Hunter | Biotech Hunter